In a filing, Twist Bioscience Corp revealed its Chief Financial Officer Laponis Adam unloaded Company’s shares for reported $93420.0 on Jul 09 ’25. In the deal valued at $38.15 per share,2,449 shares were sold. As a result of this transaction, Laponis Adam now holds 103,569 shares worth roughly $3.6 million.
Then, Laponis Adam bought 2,449 shares, generating $93,419 in total proceeds.
Before that, Cho Dennis sold 125 shares. Twist Bioscience Corp shares valued at $4,524 were divested by the insider at a price of $36.19 per share. As a result of the transaction, Cho Dennis now holds 104,612 shares, worth roughly $3.64 million.
Wolfe Research initiated its Twist Bioscience Corp [TWST] rating to an Outperform in a research note published on December 13, 2024; the price target was $60. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in early June with a ‘”a Buy”‘ rating. Goldman also remained covering TWST and has increased its forecast on January 17, 2024 with a “Buy” recommendation from previously “Neutral” rating. Berenberg started covering the stock on September 27, 2023. It rated TWST as “a Buy”.
Price Performance Review of TWST
On Monday, Twist Bioscience Corp [NASDAQ:TWST] saw its stock fall -1.14% to $34.77. Over the last five days, the stock has lost -8.02%. Twist Bioscience Corp shares have fallen nearly -38.15% since the year began. Nevertheless, the stocks have fallen -25.18% over the past one year.
How much short interest is there in Twist Bioscience Corp?
A steep rise in short interest was recorded in Twist Bioscience Corp stocks on 2025-06-13, dropping by -0.31 million shares to a total of 10.31 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 10.62 million shares. There was a decline of -2.98%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 05, 2023 when Scotiabank began covering the stock and recommended ‘”a Sector outperform”‘ rating along with a $33 price target.
